Results 11 to 20 of about 4,181 (175)

Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and Preeclampsia [PDF]

open access: yesJIMD Reports, Volume 66, Issue 4, July 2025.
ABSTRACT Little is known about pregnancies and placental changes in women with glycogen storage disease type Ia (GSD Ia). We report on two primipara with GSD Ia who both developed preeclampsia and whose newborns were small for gestational age. Both placentas showed sonomorphological and macroscopical abnormalities.
V. Laufs   +7 more
wiley   +2 more sources

The Allelic and Phenotypic Frequencies of the ABO and Rh Blood Types in Pregnant Women in Addis Ababa, Ethiopia [PDF]

open access: yesBioMed Research International, Volume 2025, Issue 1, 2025.
Background: ABO–rhesus (Rh) blood testing screens blood types according to the antigenic properties of red blood cells. Objective: This study reports the allelic and phenotypic frequency distribution of the ABO and Rh blood groups in pregnant women who attended antenatal care (ANC) at Zewditu Memorial Hospital in Addis Ababa, Ethiopia, and the ...
Mekdes Wondiye Tedbabe   +3 more
wiley   +2 more sources

Comparison of intrauterine transfusion techniques in hemolytic disease of the fetus and newborn [PDF]

open access: yesUltrasound in Obstetrics &Gynecology, Volume 65, Issue 5, Page 589-596, May 2025.
ABSTRACT Objectives Intrauterine transfusions (IUTs) are the cornerstone in treatment for hemolytic disease of the fetus and newborn (HDFN). It has been suggested that a non‐vascular intraperitoneal blood transfusion used in conjunction with an intravascular IUT can slow the decrease in fetal hemoglobin (Hb) levels, potentially extending the interval ...
R. M. van 't Oever   +8 more
wiley   +2 more sources

Non-RhD alloimmunization in pregnancy: an updated review [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
RhD alloimmunization in pregnancy is still the main cause of hemolytic disease of the fetus and neonate (HDFN). Nevertheless, there are other antigens that may be associated with the occurrence of this phenomenon and that have been growing in proportion,
Sabrina Menes Ares   +3 more
doaj   +2 more sources

Prevalence of erythrocyte alloimmunization in polytransfused patients [PDF]

open access: yesEinstein (São Paulo), 2011
Objective: To determine the incidence and the rate of red blood cell alloimmunization in polytransfused patients. Methods: A polytransfused patient was defined as having received at least 6 units of red cell concentrates during a 3-month period.
Roberto de Oliveira Cruz   +6 more
doaj   +3 more sources

ERYTHROBLASTOSIS AND FETAL GROWTH RETARDATION (IUGR) [PDF]

open access: yesPediatric Research, 1987
Top of pageAbstract Little has been published about circulating nucleated red blood cells (NRBC) in very low birth weight (VLBW) infants. We saw marked erythroblastosis (increased NRBC) in several infants with severe IUGR who were also VLBW. Hence, we evaluated the NRBC of all VLBW infants admitted to our intensive care nursery in 1983-86.
A M Tito, Alistair G.S. Philip
openaire   +2 more sources

Immunotoxicity assessment of rice-derived recombinant human serum albumin using human peripheral blood mononuclear cells. [PDF]

open access: yesPLoS ONE, 2014
Human serum albumin (HSA) is extensively used in clinics to treat a variety of diseases, such as hypoproteinemia, hemorrhagic shock, serious burn injuries, cirrhotic ascites and fetal erythroblastosis.
Kai Fu   +11 more
doaj   +1 more source

Yolk sac development, function and role in rodent pregnancy

open access: yesBirth Defects Research, Volume 115, Issue 14, Page 1243-1254, August 15, 2023., 2023
Abstract During the early phases of embryonic development, the yolk sac serves as an initial placenta in many animal species. While in some, this role subsides around the end of active organogenesis, it continues to have important functions in rodents, alongside the chorio‐allantoic placenta.
Asher Ornoy, Richard K. Miller
wiley   +1 more source

Symphony in the crowd: Key genetic alterations in prostate cancer

open access: yesCancer Innovation, Volume 2, Issue 3, Page 203-209, June 2023., 2023
Genetic alterations in prostate cancer (PCa). PCa progresses from a recurrent inflammation of the prostatic epithelia to an aggressive form. The key genetic alterations during this conversion include: altered androgen receptor (AR), gene fusion, alteration of tumor suppressors, defective DNA repair mechanism.
Neshat Masud
wiley   +1 more source

An intriguing case of a paravertebral extramedullary erythropoiesis presenting as tumor‐mimicking lesion in a patient with eosinophilia with FIP1L1‐PDGFRA rearrangement

open access: yesClinical Case Reports, Volume 10, Issue 12, December 2022., 2022
This is the first reported case of extramedullary hematopoiesis interesting only one cell lineage (erythrocytes) presenting as an isolated tumor‐like lesion in the posterior mediastinum in a 28‐year‐old man with a 13‐year history of eosinophilia with FIP1L1‐PDGFRA fusion gene successfully surgically treated. Abstract Extramedullary hematopoiesis in the
Sassi Farah   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy